Armata Pharmaceuticals, Inc. (ARMP)
NYSEAMERICAN: ARMP · Real-Time Price · USD
4.540
-0.240 (-5.02%)
Jul 31, 2026, 4:00 PM EDT - Market closed
Armata Pharmaceuticals Employees
Armata Pharmaceuticals had 61 employees as of December 31, 2025. The number of employees increased by 1 or 1.67% compared to the previous year.
Employees
61
Change (1Y)
1
Growth (1Y)
1.67%
Revenue / Employee
$85,279
Profits / Employee
-$4,633,016
Market Cap
166.67M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 61 | 1 | 1.67% | 61 | 0 |
| Dec 31, 2024 | 60 | -6 | -9.09% | 60 | 0 |
| Dec 31, 2023 | 66 | -9 | -12.00% | 66 | 0 |
| Dec 31, 2022 | 75 | 4 | 5.63% | 72 | 3 |
| Dec 31, 2021 | 71 | 9 | 14.52% | 69 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 184 |
| Innate Pharma | 164 |
| Invivyd | 122 |
| Arcturus Therapeutics Holdings | 111 |
| Alector | 103 |
| Camp4 Therapeutics | 48 |
| OnKure Therapeutics | 45 |
| Corbus Pharmaceuticals Holdings | 36 |
ARMP News
- 11 days ago - Armata provides update on AP-SA02 studies - TheFly
- 11 days ago - Armata Pharmaceuticals Achieves Key Progress Across Clinical, Regulatory and Manufacturing Activities Supporting Planned Phase 3 Initiation of AP-SA02 - PRNewsWire
- 18 days ago - Armata Pharmaceuticals reaches agreement with FDA on iPSP for AP-SA02 - TheFly
- 18 days ago - Armata Pharmaceuticals Receives Agreement from FDA on Initial Pediatric Study Plan for AP-SA02 for the Treatment of Complicated Staphylococcus aureus Bacteremia - PRNewsWire
- 5 weeks ago - Armata Pharmaceuticals granted $2.5M additional non-dilutive award funding - TheFly
- 5 weeks ago - Armata Pharmaceuticals Receives $2.5 Million of Additional Non-Dilutive Award Funding from the U.S. Department of Defense to Support AP-SA02 - PRNewsWire
- 7 weeks ago - Armata Pharmaceuticals Slides: Corporate presentation - Filings
- 2 months ago - Armata Pharmaceuticals reports Q1 EPS ($3.16) vs. (20c) last year - TheFly